Nu Wave Investment Management, LLC Neurocrine Biosciences Inc Transaction History

Nu Wave Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$75.79 - $100.07 $6,745 - $8,906	-89 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$72.45 - $94.81 $330,879 - $432,997	-4,567 Reduced 98.09%	89 $8,000
Q4 2021 Jan 18, 2022	BUY	$79.65 - $106.22 $370,850 - $494,560	4,656 New	4,656 $397,000
Q1 2021 Apr 09, 2021	SELL	$87.57 - $119.4 $66,378 - $90,505	-758 Closed	0 $0
Q4 2020 Jan 11, 2021	SELL	$86.91 - $108.33 $201,457 - $251,108	-2,318 Reduced 75.36%	758 $73,000
Q3 2020 Oct 23, 2020	BUY	$96.16 - $135.15 $295,788 - $415,721	3,076 New	3,076 $296,000

650

96.2M

380K

382K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.